Digostics Limited
Digostics and AgaMatrix Team Up to Improve Gestational Diabetes Screening for UK Women via the Introduction of Oral Glucose Tolerance Home Testing
OXFORD, UK / ACCESSWIRE / April 10, 2024 / Digital clinical diagnostics and diabetes home testing provider Digostics Limited announced today a new commercial partnership with leading diabetes technology company, AgaMatrix Europe Limited, designed to accelerate the introduction of Digostics' home oral glucose tolerance testing (OGTT) service, GTT@home, for gestational diabetes (GDM) screening within the UK National Health Service (NHS).
GTT@home represents the world's first and only commercially available OGTT approved for home use. The partnership enables AgaMatrix to distribute GTT@home to the NHS on an exclusive basis. This news also follows the recent announcement of the significantly improved uptake in OGTT attributed to home testing experienced by University Hospital Southampton (UHS), and GTT@home's full inclusion in the Laboratory Diagnostics, Point of Care Testing and Pathology Managed Services framework operated by NHS Supply Chain.
Image: The GTT@home Test Kit includes the novel test device, a preformulated glucose drink, finger prickers, a test user guide and a prepaid envelope. It is packaged to fit safely in the recipient's home letterbox.
"The significant reductions in maternity services workload and improvements in test accessibility achieved by taking GDM screening directly to the expectant mother has generated huge domestic and international demand for GTT@home," said James Jackson, CEO and Founder of Digostics. "AgaMatrix is the perfect partner to help Digostics expedite GTT@home's UK introduction based on its existing relationships and customer base within NHS maternity services and their unparalleled domain expertise in GDM monitoring."
While the OGTT is the gold standard in GDM screening, delayed and missed tests are common based on the inconvenience for women and complexity for healthcare providers of the traditional clinic-based method of OGTT delivery. OGTT uptake is also unfortunately lowest with those patient groups most at-risk of developing the condition.
GTT@home removes the barriers associated with effective diabetes screening by enabling women to test for glucose intolerance outside of the clinic for the very first time. Home testing offers the same level of accuracy as clinic tests but without any of the staffing requirements, risks of sample degradation and laboratory delays that often impact clinic testing capacity, contribute to screening backlogs and cause false negative tests.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Image: With GTT@home, the user can send their test data directly to their antenatal care team with a simple scan of a snap-off fob attached to the test device using the NFC functionality within their smartphone.
"Our daily interaction with customers means we see up close just how difficult it is for maternity service departments to deliver timely GDM testing. We also know just how excited they are at the prospect of being able to improve their testing throughput by introducing home screening," said Alec Winton, Business Manager Europe, AgaMatrix Europe. "We could not be more excited to partner with Digostics and to add GTT@home to our growing portfolio of ways in which we can assist the NHS manage diabetes in pregnancy."
With GTT@home simplifying GDM testing and AgaMatrix' technologies assisting with the management of those diagnosed positive, the partnership also provides additional scope for a closer technical integration between their respective solutions.
"The complementary nature of Digostics' and AgaMatrix' services bridges a technical gap between GDM testing and post-diagnosis care," said Arif Govani, Chief Digital and Data Officer, Digostics. "However, we are not stopping there in our efforts to make things easier for diabetes midwifery professionals. We are already exploring ways in which we can make the testing and diabetes patient onboarding process even more seamless through full-service integration."
NHS Supply Chain's Laboratory Diagnostics, Point of Care Testing and Pathology Managed Services framework started on the 12th March 2024 and runs for four years. GTT@home's inclusion on this framework makes it easier for NHS hospitals looking to reduce their testing backlogs by drawing on the Digostics service. GTT@home is also regulatory approved for use within the European Union. Additionally, Digostics is currently launching international operations in the Middle East and Asia Pacific to meet the significant demand for oral glucose tolerance home testing in these regions.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.***
About Digostics
Far too many people across the world are living with undiagnosed diabetes.
UK-based Digostics' mission is to enable healthcare providers to identify everyone with diabetes, and those at risk of developing diabetes, by eliminating the common barriers that inhibit accurate and timely testing using the gold standard oral glucose tolerance test (OGTT).
Digostics is proud to offer GTT@home - the world's first home OGTT offering and the most accessible and scalable way for clinical teams to realise their diabetes testing objectives.
To learn more, visit www.digostics.com
About AgaMatrix Europe Ltd
AgaMatrix Europe Ltd is a wholly owned subsidiary of AgaMatrix Inc. based in New Hampshire, USA. AgaMatrix Inc. was acquired by global in-vitro diagnostics company, i-SENS, in July 2023.
AgaMatrix designs, develops, manufactures, and supplies innovative diagnostic and data management technologies for diabetes care.
AgaMatrix Europe is a leading supplier of blood glucose monitoring and support services to Gestational Diabetes Clinics nationwide. The WaveSense JAZZ™ blood glucose test strip is the second most prescribed in the UK. It is used in the WaveSense JAZZ™ WIRELESS meter, which syncs automatically to the AgaMatrix Diabetes Manager app, and is a popular choice for HCPs to monitor Gestational Diabetes.
AgaMatrix has sold over 8 million blood glucose monitors and over 3 billion test strips since the Company's 2001 inception.
Media Contact(s)
Graeme Collins, Digostics
Mobile: +44 (0)7854 664168
Email: gc@digostics.com
SOURCE: Digostics Limited
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
The First $5M: Andreas Geldstrom from GENERALIFX Shares His AI-Powered Investment Strategies in an Exclusive Webinar13.3.2025 11:30:00 CET | Press release
Live Webinar on March 21st at 18:30 CET - Registration Now Open ZURICH, SWITZERLAND / ACCESS Newswire / March 13, 2025 / GENERALIFX, a leading provider of investment education, is set to host an exclusive live webinar featuring Andreas Geldstrom, a renowned financial strategist and AI-driven trading expert. The event, scheduled for March 21st at 18:30 CET, will reveal the key strategies that have helped traders achieve their first $5 million in profits using AI-powered investment techniques. As the financial industry continues to evolve, artificial intelligence is reshaping trading and investment strategies, enabling traders to identify market opportunities with greater accuracy and efficiency. GENERALIFX has been at the forefront of this revolution, equipping investors with the knowledge and tools needed to navigate the markets successfully. Webinar Highlights: The Role of AI in Trading: How machine learning is transforming market analysis and decision-making. Effective Risk Managemen
MicroVision To Announce Fourth Quarter and Full Year 2024 Results on March 26, 202512.3.2025 16:05:00 CET | Press release
REDMOND, WA / ACCESS Newswire / March 12, 2025 / MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, today announces that it will report its fourth quarter and full year 2024 financial results on Wednesday, March 26, 2025 after the market close. The Company will subsequently hold a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session at 1:30 PM PT/4:30 PM ET on Wednesday, March 26, 2025 to discuss the financial results and provide a business update. Analysts and investors may pose questions for management during the live webcast on March 26, 2025, and may submit questions HERE in advance of the conference call. The live webcast and slide presentation can be accessed on the Company's Investor Relations website under the Events tab HERE. The webcast will be archived on the website for future viewing. About MicroVision MicroVision drives global
Curve Energy Corp. And Lot 49 Capital Corp. Sign Definitive Agreement for Amalgamation and TSX Venture Listing11.3.2025 18:35:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / March 11, 2025 / Curve Energy Corp. (the "Company" or "Curve") and Lot 49 Capital Corp. ("Lot 49") are pleased to announce that they have entered into a definitive agreement (the "Definitive Agreement") to combine the two companies (the "Transaction") which will constitute a reverse takeover transaction ("RTO") of Lot 49. The Transaction is structured to facilitate the listing of the combined entity on the TSX Venture Exchange ("TSXV"). The Transaction is expected to be completed by way of a three-cornered amalgamation under the provisions of the Business Corporations Act (British Columbia) whereby a wholly-owned subsidiary of Lot 49 ("SubCo"), will amalgamate with Curve. All of the issued and outstanding common shares of SubCo and Curve following the amalgamation will be immediately exchanged for common shares of Lot 49 ("Lot 49 Shares") on a one-for-one basis. In connection with closing of the Transaction, Lot 49 intends to settle approximately $138,
Bear Robotics' Carti 100 Wins iF DESIGN AWARD 2025, Setting New Standards in Logistics Automation11.3.2025 11:58:00 CET | Press release
REDWOOD CITY, CA / ACCESS Newswire / March 11, 2025 / Bear Robotics is thrilled to announce that its Carti 100 autonomous mobile robot has been awarded the prestigious iF DESIGN AWARD 2025 in the Product category, Robotics discipline. This achievement reinforces Bear Robotics' position as a leader in innovative robotic design for logistics, building upon the success of the Servi Plus award earlier last year. Carti 100 stood out among nearly 11,000 entries from 66 countries, impressing a panel of 131 international design experts. The iF DESIGN AWARD, recognized globally as a symbol of design excellence, underscores Bear Robotics' commitment to merging cutting-edge technology with user-centric design. Designed by Bear Robotics' in-house design and engineering teams in Silicon Valley, Carti 100 is engineered to revolutionize indoor logistics. Capable of carrying loads up to 220 lbs, and offering extensive customization options, Carti 100 integrates seamlessly into diverse operational envi
Formerra Introduces Formerra+ Upgraded Ecommerce Site to Optimize Customer Experience11.3.2025 09:15:00 CET | Press release
Formerra+™ delivers a faster, smarter, and more seamless way to do business with enhanced product search, intuitive navigation, and powerful management tools. ROMEOVILLE, IL / ACCESS Newswire / March 11, 2025 / Formerra, a leader in performance materials distribution, today launched the Formerra+ ecommerce website, now upgraded to deliver a faster, more intuitive, and personalized experience for customers across multiple industries. The enhanced site provides purchasing, engineering, and quality control customers with easy access to ordering and technical information so that they can get the materials they need faster. "Our customers are looking for efficiency, accuracy, and convenience when managing orders and purchasing materials," said Cathy Dodd, Chief Executive Officer at Formerra. "The upgraded Formerra+ online and mobile experience reflects our commitment to delivering the best digital tools and 24/7 ordering experience to customers worldwide." Formerra+ offers simplified naviga
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom